MediciNova rises ~9% after hours on Canadian nod to start long COVID-19 treatment trial

Feb. 08, 2023 6:22 PM ETMediciNova, Inc. (MNOV)By: Anuron Mitra, SA News Editor1 Comment

Masked Asian man show wooden sign with wording "Long Covid"


  • MediciNova (NASDAQ:MNOV) on Wednesday said Canada's drug regulator had cleared the company to start a trial to evaluate its treatment of the lingering symptoms of COVID-19, called "Long COVID."
  • Shares of MNOV rose 8.5% to $2.56 after hours.
  • The company

Recommended For You

Comments (1)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.